Consultant Survey |
1. Basic Information
| 11% |
These are exciting times for clinical pharmacology and therapeutics. We are emerging from a period during which our numbers have fallen and others outside the specialty seem to have shown little interest in promoting it. Now, however, many others are beginning to show that they realize the importance of teaching the principles of clinical pharmacology and the practical aspects of therapeutics, including prescribing, and that it should be clinical pharmacologists who do it.
The pace of change in attitudes to clinical pharmacology during the past four years, and particularly during the last year, has been impressive. For example, the Office for Life Sciences, established by the previous Government under the leadership of Lord Drayson, the then Minister for Science and Innovation, has issued two seminal reports under the general title “Life Sciences Blueprint”, establishing the need for further developments in clinical pharmacology.
This questionnaire seeks important information that will guide future discussions about this. In addition to asking specific questions, it allows you to add comments about other aspects that we may not have covered.
Jeff Aronson
President Emeritus, BPS
The pace of change in attitudes to clinical pharmacology during the past four years, and particularly during the last year, has been impressive. For example, the Office for Life Sciences, established by the previous Government under the leadership of Lord Drayson, the then Minister for Science and Innovation, has issued two seminal reports under the general title “Life Sciences Blueprint”, establishing the need for further developments in clinical pharmacology.
This questionnaire seeks important information that will guide future discussions about this. In addition to asking specific questions, it allows you to add comments about other aspects that we may not have covered.
Jeff Aronson
President Emeritus, BPS